BackPfizer Overview

Pfizer Total Liabilities

Latest total liabilities for PFE.DE: $120B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$115.64B
↓ 1.23% YoYΔ $-1.44B vs prior year quarter

Peer trimmed avg / median

Loading

Pfizer Total Liabilities History

Loading

Pfizer vs. peers: Total Liabilities Comparison

Loading

Pfizer Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pfizer (PFE.DE) FAQ

As of the most recent data (June 2026), PFE.DE shows a total liabilities of $120B. That compares with $120B in the prior-year period — down 1.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PFE.DE's total liabilities is now $120B (was $120B) — a 1.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pfizer is outperforming or lagging.

Tracking PFE.DE's total liabilities over time shows whether Pfizer is scaling, shrinking, or reshaping that part of the business. The current reading is $120B That compares with $120B in the prior-year period — down 1.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Pfizer's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $120B) with ownership activity and broader fundamentals.

Pfizer's total liabilities is $120B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.